How big is the Transdermal Skin Patches Market?

The Transdermal Skin Patches Market size is expected to reach USD 8.92 billion in 2024 and grow at a CAGR of 4.87% to reach USD 11.33 billion by 2029. Read More

What is the current Transdermal Skin Patches Market size?

In 2024, the Transdermal Skin Patches Market size is expected to reach USD 8.92 billion. Read More

Who are the key players in Transdermal Skin Patches Market?

Teva Pharmaceuticals USA Inc., Novartis AG, Teikoku Pharma USA, Inc., Viatris, Inc. and Johnson & Johnson are the major companies operating in the Transdermal Skin Patches Market. Read More

Which is the fastest growing region in Transdermal Skin Patches Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Transdermal Skin Patches Market?

In 2024, the North America accounts for the largest market share in Transdermal Skin Patches Market. Read More

What years does this Transdermal Skin Patches Market cover, and what was the market size in 2023?

In 2023, the Transdermal Skin Patches Market size was estimated at USD 8.51 billion. The report covers the Transdermal Skin Patches Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Transdermal Skin Patches Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Transdermal Skin Patches Companies

This report lists the top Transdermal Skin Patches companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Transdermal Skin Patches industry.